Direct Royalties. Licensee agrees to pay and shall pay to CSMC a running royalty of three and three-quarters percent (3.75%) on Net Sales of Products made, used, sold or otherwise distributed by Licensee hereunder (each, a “Direct Royalty”).
Appears in 2 contracts
Sources: Exclusive License Agreement (Kairos Pharma, LTD.), Exclusive License Agreement (Kairos Pharma, LTD.)
Direct Royalties. Licensee agrees to pay and shall pay to CSMC (on behalf of Licensors) a running royalty of three and three-quarters percent (3.75%) on Net Sales of Products made, used, sold or otherwise distributed by Licensee hereunder (each, a “Direct Royalty”).
Appears in 1 contract